Recruiting
Phase 3

Neoadjuvant Chemotherapy vs. Chemoradiotherapy

Sponsor:

Canadian Cancer Trials Group

Code:

NCT06205485

Conditions

Rectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Leucovorin

Oxaliplatin

Fluoruracil

Capecitabine

Radiation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-11. This information was provided to ClinicalTrials.gov by Canadian Cancer Trials Group on 2025-03-11.